Boxer Capital as of June 30, 2019
Portfolio Holdings for Boxer Capital
Boxer Capital holds 35 positions in its portfolio as reported in the June 2019 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Mirati Therapeutics | 15.5 | $177M | 1.7M | 103.00 | |
| Odonate Therapeutics Ord | 10.8 | $123M | 3.4M | 36.69 | |
| Beigene (ONC) | 9.8 | $112M | 900k | 123.95 | |
| Immunomedics | 8.0 | $91M | 6.6M | 13.87 | |
| Spark Therapeutics | 5.4 | $61M | 600k | 102.38 | |
| Uniqure Nv (QURE) | 4.2 | $48M | 615k | 78.15 | |
| Esperion Therapeutics (ESPR) | 4.0 | $45M | 975k | 46.52 | |
| Ptc Therapeutics I (PTCT) | 3.9 | $45M | 1.0M | 45.00 | |
| Dbv Technologies S A | 3.8 | $44M | 5.3M | 8.22 | |
| Gossamer Bio (GOSS) | 3.6 | $42M | 1.9M | 22.18 | |
| Atreca Inc Cl A (BCEL) | 2.9 | $33M | 1.7M | 18.84 | |
| Milestone Pharmaceuticals (MIST) | 2.6 | $30M | 1.1M | 27.15 | |
| Amicus Therapeutics (FOLD) | 2.5 | $29M | 2.3M | 12.48 | |
| Argenx Se (ARGX) | 2.5 | $28M | 200k | 141.58 | |
| Medicines Company | 2.4 | $27M | 750k | 36.47 | |
| Wave Life Sciences (WVE) | 2.3 | $26M | 1.0M | 26.09 | |
| Rocket Pharmaceuticals (RCKT) | 1.9 | $22M | 1.5M | 15.00 | |
| Allakos | 1.8 | $21M | 475k | 43.33 | |
| Solid Biosciences | 1.8 | $20M | 3.5M | 5.75 | |
| Kura Oncology (KURA) | 1.4 | $17M | 845k | 19.69 | |
| Prevail Therapeutics Ord | 1.3 | $15M | 1.1M | 13.20 | |
| Global Blood Therapeutics In | 1.1 | $13M | 250k | 52.60 | |
| Cymabay Therapeutics | 0.8 | $9.0M | 1.3M | 7.16 | |
| Matinas Biopharma Holdings, In | 0.8 | $8.8M | 10M | 0.86 | |
| Mersana Therapeutics | 0.7 | $8.4M | 2.1M | 4.05 | |
| Ideaya Biosciences (IDYA) | 0.7 | $7.6M | 764k | 9.96 | |
| Kadmon Hldgs | 0.7 | $7.6M | 3.7M | 2.06 | |
| Akero Therapeutics (AKRO) | 0.7 | $7.6M | 397k | 19.15 | |
| Mei Pharma | 0.6 | $7.3M | 2.9M | 2.50 | |
| La Jolla Pharmaceuticl Com Par | 0.5 | $5.3M | 575k | 9.25 | |
| Kalvista Pharmaceuticals (KALV) | 0.4 | $4.4M | 200k | 22.15 | |
| Kiniksa Pharmaceuticals | 0.3 | $3.9M | 291k | 13.54 | |
| Voyager Therapeutics (VYGR) | 0.2 | $2.7M | 100k | 27.22 | |
| Cellectar Biosciences | 0.2 | $2.0M | 920k | 2.18 | |
| Novus Therapeutics | 0.0 | $328k | 324k | 1.01 |
